Concepedia
Statistics
Publications
6
Citations
97
H-Index
Active since
2016
Affiliations
Biothera (United States)(Current)
Biota Pharmaceuticals (United States)
South Texas Accelerated Research Therapeutics
Texas Oncology
University of Chicago Medical Center
Takashi Kangas is an author at Biothera (United States) specializing in cancer immunotherapy, immunology, and oncology.
Publications per year
2016–2024
Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies
Anissa Chan, Takashi Kangas, Xiaohong Qiu et al. · Frontiers in Oncology · 2022 · 19 citations · Full text
Life Sciences, Immunology, Oncology +17
CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes
Jason S. Mitchell, Justin A. Spanier, Alexander J. Dwyer et al. · Immunity · 2024 · 19 citations · Full text
Life Sciences, Endocrinology, Immunology +17
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts
Sonja Althammer, Keith E. Steele, Marlon C. Rebelatto et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text
Medicine, Immunology, Oncology +17
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text
Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy Volunteers
Nandita Bose, Nadine Ottoson, Xiaohong Qiu et al. · The Journal of Immunology · 2019 · 14 citations
Medicine, Immunology, Pharmacology +17
1–5 of 6